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CD16 is a major molecule expressed on NK cells. To directly assess the role of natural 47 
killer (NK) cells in dengue virus (DENV) infection in vivo, CD16 antibody-treated 48 
tamarins were inoculated with DENV-2 strain. This resulted in the transient depletion of 49 
CD16+ NK cells, whereas no significant effects on the overall levels or kinetics of 50 
plasma viral loads and anti-viral antibodies were observed in the treated monkeys as 51 
compared to those in the control monkeys. It remains elusive whether CD16- NK 52 
subpopulation could play an important role in the control of primary DENV infection.  53 
54 
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DENV is one of the most serious mosquito-borne virus affecting humans with 2.5 54 
billion people at risk in tropical and subtropical regions around the world each year [12]. 55 
A wide variety of clinical manifestations have been noted, which range from 56 
asymptomatic, mild febrile illness (dengue fever [DF]) to dengue hemorrhagic fever 57 
(DHF)/dengue shock syndrome (DSS), a life-threatening illness. It has been shown that 58 
humans with a secondary heterologous DENV infection are at a higher risk of 59 
contracting severe dengue disease [10, 26]. DHF/DSS occurs in infants during primary 60 
DENV infection predominantly in the second half of the first year of life when maternal 61 
antibodies have low residual neutralizing activity [11, 17]. 62 
      NK cells are a component of the innate immune system that plays a central role 63 
in host defense against viral infection and tumor cells. It has been shown that infection 64 
by some viruses, such as herpes simplex virus-1, influenza virus or the ectromelia 65 
poxvirus, can be controlled by NK cells in mice [15]. Yet the most compelling evidence 66 
for a role of NK cells in early defense against viruses was obtained in a study showing 67 
increased susceptibility or resistance to murine cytomegalovirus (MCMV) after NK cell 68 
depletion or NK cell adoptive transfer, respectively [23]. Defects in NK cell activity, 69 
such as decreased production of interferon (IFN)-γ or cytotoxicity, render mice more 70 
susceptible to MCMV infection [23]. NK cells can kill virus-infected cells by using 71 
cytotoxic granules or by recognizing and inducing lyses of antibody-coated target cells 72 
(antibody-dependent cell cytotoxicity) via Fc binding receptor such as CD16 [21].  73 
      Early activity of NK cells may be important for clearing primary DENV 74 
infection [24]. In a DENV mouse model, mice experimentally infected with DENV 75 
showed increased NK cell levels [24]. A significant increase in the frequency of NK cell 76 
circulation was also shown in patients who developed an acute dengue disease [2]. In 77 
addition, patients with a mild dengue disease have elevated NK cell rates when 78 
compared to those with severe dengue diseases [9, 27]. Moreover, Kurane et al. 79 
reported that human blood NK cells are cytotoxic against DENV-infected cells in target 80 
organs via direct cytolysis and antibody-dependent cell-mediated cytotoxicity [14]. It 81 
was also shown that the intracellular cytotoxic granule, TIA-1, was up-regulated early 82 
in NK cells in the acute phase of DENV infection and that NK-activating receptor 83 
NKp44 was involved in virus-mediated NK activation through direct interaction with 84 
DENV envelope protein [2, 13]. These results suggest that the early activation of NK 85 
cells contributes to the prevention of the severe dengue disease. However, based on 86 
quantitative and functional analyses in animal model in vivo, defining the contribution 87 
of NK cells to suppress DENV replication in vivo has been necessary.  88 
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      We have recently reported that common marmosets (Callithrex jacchus) are 89 
highly permissive to DENV infection [22]. The New World monkeys, being nonhuman 90 
primates are considered to have a similar immune system to humans [28, 29]. The 91 
present study was initiated to investigate the role of NK cells in controlling DENV 92 
during primary infection in our nonhuman primate model.  93 
      The animals were cared for in accordance with National Institute of Biomedical 94 
Innovation rules and guidelines for experimental animal welfare, and all protocols were 95 
approved by our Institutional Animal Study Committee. Eight tamarins (Saguinus 96 
midas and Saguinus labiatus) were used in this study. As marmosets and tamarins are 97 
closely related monkey species and are classified into Callitrichinae, we expected that 98 
tamarins would also be permissive to DENV infection as well as marmosets. To check 99 
the permissiveness of tamarins to DENV, 2 tamarins were infected with DENV-2 100 
(DHF0663 strain: 6.7x107 PFU/ml) subcutaneously or intravenously (Fig. 1). Dengue 101 
viral RNA (vRNA), which was quantified using real-time PCR as previously described 102 
[22], was detected in plasma samples from the tamarins on day 1 post-infection. For 103 
each of the two tamarins (Tm03-011, Tm06-017), the plasma vRNA levels reached 104 
2.7x106 copies/ml and 2.0x107 copies/ml on day 1 post-infection, respectively, and were 105 
detectable on days 3 and 5. These results indicate that tamarins are also permissive to 106 
DENV infection, which is consistent with the results obtained by using marmosets [22]. 107 
      Next, we sought to assess the role of NK cells in DENV infection in vivo. In this 108 
regard, in vivo depletion of NK cells by the administration of NK-specific monoclonal 109 
antibody (mAb) was considered to be straightforward to directly address the question. 110 
We employed a new method by which an anti-CD16 mAb 3G8 [7] but not a control 111 
mAb MOPC-21 efficiently depleted a major NK population expressing CD16 in 112 
tamarins, as we recently reported [29]. The mouse anti-human CD16 mAb 3G8 was 113 
produced in serum-free medium and purified using protein A affinity chromatography. 114 
Endotoxin levels were confirmed to be lower than 1 EU/mg. Four red-handed tamarins 115 
and two white-lipped tamarins (Saguinus labiatus) were used in this experiment. Three 116 
tamarins were intravenously administered 3G8 at a dose of 50 mg/kg, while others were 117 
given a control mAb MOPC-21. One day later, both mAb-treated tamarins were 118 
subcutaneously inoculated with 3x105 PFU/ml of DENV-2 DHF0663 strain on the basis 119 
of a previous report that a single mosquito might inject between 104 and 105 PFU of 120 
DENV into a human [20]. It was confirmed that at 1-3 days after the 3G8 mAb 121 
treatment, CD16+ cells were almost completely depleted in the tamarins followed by 122 
recovery to the initial levels at around 2 weeks after administration, while the cells were 123 
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maintained at the initial levels in the monkeys with MOPC-21 (Fig. 2A). In addition, it 124 
is noteworthy that the ratios of CD4+ and CD8+ T cells and CD20+ B cells were not 125 
affected by the administration of the 3G8 mAb (Supplementary Figure 1). In the case of 126 
the MOPC-21 mAb administration, we confirmed no significant effect on CD16+ cells 127 
(Supplementary Figure 2). The killing activities of the peripheral blood mononuclear 128 
cells (PBMCs) taken from the 3G8-treated monkeys were reduced at day 1 post 129 
antibody-treatment, followed by increase irrespective of depletion of CD16+ NK cells at 130 
day 2 post antibody-treatment (1 day after DENV inoculation), suggesting that CD16- 131 
NK population may be activated by DENV infection (Fig. 2B). Plasma viral loads in 132 
both mAb-treated monkeys rose to 105 copies/ml by day 1 after infection and then 133 
reached a peak at 106 copies/ml on day 3 or day 7 followed by a rapid decline with 134 
values dipping below the detectable level by day 14 after infection (Fig. 2C). These 135 
results suggested that CD16+ NK cells did not apparently contribute to DENV 136 
replication in the acute phase in our tamarin model.  137 
      It was previously reported that non-structural glycoprotein NS1 was essential for 138 
flavivirus viability and the NS1 protein circulated during the acute phase of disease in 139 
the plasma of patients infected with DENV [1]. Epidemiological studies have 140 
demonstrated that secreted NS1 levels are correlated with viremia levels and are higher 141 
in DHF than in dengue fever (DF) early in illness [16], thus it has been suggested that 142 
NS1 might be a useful marker as an indicator of the severity of dengue disease. We 143 
have used the value of the NS1 antigens as an alternative diagnostic marker to examine 144 
the effects of CD16 antibody treatment on DENV replication. The NS1 was measured 145 
by Platelia Dengue NS1 Ag assay (BioRad). Antigenemia was noted in these infected 146 
monkeys between 3-14 days post-infection. Serum IgM and IgG specific for DENV 147 
antigens were measured by ELISA. DENV specific IgM or IgG antibody was equally 148 
detected in both mAb-treated monkeys.  149 
      We recently demonstrated that marmosets were permissive to DENV infection 150 
[22]. In this study, we found that tamarins were also permissive to DENV infection 151 
(Fig.1). Moreover, we also investigated the role of NK cells against early DENV 152 
infection using in vivo depletion of CD16+ NK cells in tamarins. As a result, the 153 
depletion of CD16+ NK cells had almost no effect on DENV replication (Fig. 2), and 154 
thus the NK subpopulation was unlikely to contribute to controlling DENV replication. 155 
Interestingly, these results imply that CD16- NK subpopulation may have a critical role 156 
of controlling DENV infection in vivo. 157 
      Using our model, we investigated the roles of NK cells in vivo against DENV 158 
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infection, which remains to be elucidated in several aspects. We previously reported 159 
that almost complete in vivo depletion of CD16+ NK subpopulation was not able to 160 
completely remove the NK-mediated cytotoxic activity in tamarins [29]. In this study, 161 
despite a transient but substantial reduction in CD16+ NK cell number following 3G8 162 
treatment in tamarins, DENV replication was comparable to that in monkeys with the 163 
control mAb. The NK-mediated cytotoxic activity was rather augmented in either study 164 
group, which indicates that CD16- NK cells was responsible for the cytotoxic activity 165 
and suggests that they might play a role in controlling DENV replication. 166 
      The next question is how CD16- NK cells may regulate DENV infection. One 167 
possibility regarding CD16- NK cells is that CD56+ or CD57+ NK cells are involved in 168 
controlling DENV infection. Human NK cells are classically divided into 2 functional 169 
subsets based on their cell surface density of CD56 and CD16, i.e. CD56brightCD16- 170 
immunoregulatory cells and CD56dimCD16+ cytotoxic cells. Both subsets have been 171 
characterized extensively regarding their different functions, phenotypes, and tissue 172 
localization [8]. The NK cell number is maintained by a continuous differentiation 173 
process associated with the expression of CD57 that ends in NK cells with poor 174 
responsiveness to cytokine stimulation but high cytolytic capacity [3, 18]. The second 175 
possibility is that CD16- NK cells have non-cytolytic helper function. Generally, it is 176 
well known that NK cells possess both a cytolytic and a non-cytolytic helper function. It 177 
was suggested that cytokine production is carried out by CD56brightCD16- NK cells [4-6]. 178 
Interferon (IFN)-γ secreted by NK cells has shown potent antiviral effects against 179 
DENV infection in early phases [25]. One aspect of the NK helper function arises from 180 
recent evidence indicating that NK cells can be induced to function as non-cytotoxic 181 
helper cells following stimulation with interleukin-18 [19]. This cytokine induces IFN-γ 182 
secretion from NK cells and thus enables dendritic cells (DCs) to secrete IL-12, leading 183 
to Th1 polarization [19]. It is possible that CD16- NK cells, which have poor cytotoxic 184 
activity but the enhanced ability to secrete cytokines and then to lead Th1 response, are 185 
preserved during 3G8 administration. The persistence of this minor CD16- NK cell 186 
subpopulation could exert an antiviral effect through INF-γ-mediated pathways despite 187 
the depletion of CD16+ NK cells. The third possibility is that CD16+ NK cells of 188 
tamarins play pivotal roles against bacterial infections and cancer progression but not 189 
DENV-infected cells. We will address these possibilities for the roles of the NK 190 
subpopulation in the future studies.  191 
      In conclusion, this study provides DENV replication model in vivo in 192 
tamarins and new information on the possible role of CD16+ NK cells in DENV 193 
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replication in vivo. It remains elusive whether CD16+ and CD16- NK subpopulation 194 
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Figure legends  207 
Fig. 1 Levels of vRNA in DENV-infected tamarins. Tamarins were subcutaneously or 208 
intravenously infected with DENV at a dose of 6.7x107 PFU/ml. The vRNAs were 209 
detected in plasma by real-time PCR. Tm03-011: Subcutaneously. Tm06-017: 210 
Intravenously. 211 
 212 
Fig. 2 Ratios of CD16+ NK cells, killing activity of PBMCs, and vRNA in 213 
DENV-infected tamarins after treatment of 3G8 or MOPC-21 mAb. 214 
Tamarins were subcutaneously infected with DENV at a dose 3x105 PFU/ml after 215 
treatment with 50mg/kg of 3G8 or MOPC-21 mAb. (A) Ratios of CD16+ NK cells were 216 
determined in whole blood specimens. (B) The activities of NK cells were determined 217 
in PBMCs of tamarins by NK cytotoxic assay. (C) The vRNAs were detected in plasma 218 
by real-time PCR. 219 
 220 
Fig. 3 Levels of NS1 antigen and DENV-specific IgM and IgG in plasma samples from 221 
DENV-infected tamarins after treatment of 3G8 or MOPC-21 mAb.  222 
The levels of NS1 antigen and DENV-Specific IgM and IgG in plasma were measured 223 
by ELISA. ELISA index of NS1 antigen (A), the positive/negative (P/N) ratio of 224 
DENV-specific IgM (B), and P/N ratio of DENV-specific IgG (C) in plasma samples 225 
from DENV-infected tamarins after administration of the 3G8 or MOPC-21 mAb. The 226 
P/N ratio was calculated by the formula: the optical density of the test sample divided 227 
by that of a negative sample. P/N ratios of <2 and ≥2 were considered to be negative 228 
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Supplementary Legends 
Supplementary Figure 1. Ratios of CD4+ and CD8+ T cells and CD20+ B cells after 
administration of CD16 (3G8) antibody in vivo in tamarin. 
(A-C) Tamarin was administered with 50 mg/kg of 3G8 mAb. CD4+ and CD8+ T cells 
and CD20+ B cells were determined in whole blood specimens. Tamarin: Tm 03-008. 
 
Supplementary Figure 2. Control antibody (MOPC-21) did not deplete CD16+ cells 
in vivo in tamarins. (A, B) Tamarins were administered with 50 mg/kg of the control 
antibody (MOPC-21). CD16+ NK cell numbers were determined in whole blood 
specimens. Tamarins: Tm 03-012, Tm 06-013. 
 
Supplementary materials and methods 
Animals 
All animal studies were conducted in accordance with the protocols of experimental 
procedures that were approved by the Animal Welfare and Animal Care Committee of 
the National Institute of Infectious Diseases, Japan, and the National Institute of 
Biomedical Innovation, Japan. One tamarin was used. Tamarins were caged singly at 
27±2 °C in 50±10% humidity with a 12h light-dark cycle (lighting from 7:00 to 19:00) 
at Tsukuba Primate Research Center, National Institute of Biomedical Innovation, 
Tsukuba, Japan. Animal was fed twice a day with a standard tamarin diet supplemented 
with fruit, eggs and milk. Water was given ad libitum. All animals were in a healthy 
condition and confirmed to be negative for anti-dengue virus antibodies before 




Cell culture was performed as previously described [3]. Vero cells were cultured in 
Minimum Essential Medium (MEM, Sigma) with 10% heat-inactivated fetal bovine 
serum (FBS, GIBCO) and 1% non-essential amino acid (NEAA, Sigma) at 37 °C in 5 % 




DENV strain was reported as previously described [3]. DENV type 2 (DENV-2), 
DHF0663 strain (Accession no. AB189122) strain was used for inoculation studies. The 
DENV-2, DHF0663 strain was isolated from a DHF case in Indonesia. The DENV-2 
isolated clinical samples were propagated with C6/36 cells and were used within 4 
passages on C6/36 cells. Culture supernatant from infected C6/36 cells was centrifuged 
at 3,000 rpm for 5 min to remove cell debris, and then stored at -80 °C until use. 
 
In vivo depletion of CD16 positive cells 
Mouse anti-human CD16 (3G8) mAb [2] and a mouse immunoglobulin G (IgG1κ) 
isotype-matched irrelevant control antibody (MOPC-21) were produced in serum-free 
medium and purified using protein A affinity chromatography [1]. Endotoxin levels 
were lower than 1EU/mg. Administration of CD16 antibody (3G8) or control antibody 
(MOPC-21) was performed as previously described [4]. The each antibody was 
administered to tamarin (Tm 03-008, Tm 03-012, Tm 06-013) intravenously at 50 
mg/kg at a rate of 18 ml/min using a syringe pump. Lymphocyte subsets were 
monitored for 2~3 weeks after the administration. 
  
 
Infection of marmosets with DENV 
In the challenge study, profiling of the key adaptive and innate immune cells in 
marmosets after serotype 2 of DENV (DENV-2) was examined. Marmosets were 
inoculated subcutaneously in the back with 1.8x104 or 1.8x105 PFU of the DENV-2 
DHF0663 strain [3]. Blood samples were collected on day 0, 1, 3, 7, 14, and 21 after 
inoculation. Blood samples were used for FACS analysis. Inoculation with DENV and 
blood drawing were performed under anesthesia with 5 mg/kg of ketamine 
hydrochloride. Day 0 was defined as the day of virus inoculation. 
 
Flow cytometry 
Flow cytometry was performed as previously described [4]. Fifty microliters of whole 
blood from tamarins was stained with combinations of fluorescence-conjugated 
monoclonal antibodies (mAb): anti-CD3 (SP34-2; Becton Dickinson), anti-CD4 (L200; 
BD Pharmingen), anti-CD8 (CLB-T8/4H8; Sanquin), anti-CD16 (3G8; BD 
Pharmingen) and anti-CD20 (H299; BECKMAN COULTER). Then, erythrocytes were 
lysed with FACS lysing solution (Becton Dickinson). After having been washed with 
sample buffer containing phosphate-buffered saline (PBS), 1% fetal calf serum (FCS), 
and 1% formaldehyde, the labeled cells were resuspended in the sample buffer. The 
expression of the immunolabeled molecules on the lymphocytes was analyzed with a 
FACSCanto II flow cytometer (Becton Dickinson).  
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Supplementary Fig. 2 
